We serve Chemical Name:6-bromophenanthrene-9-carboxylic acid CAS:53581-38-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-bromophenanthrene-9-carboxylic acid
CAS.NO:53581-38-7
Synonyms:3-Brom-phenanthren-10-carbonsaeure;6-bromo-phenanthrene-9-carboxylic acid;6-Bromo-9-phenanthrenecarboxylic acid;6-Bromo-9-phenanthroic acid;6-Brom-phenanthren-9-carbonsaeure
Molecular Formula:C15H9BrO2
Molecular Weight:301.13500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:482.8ºC at 760 mmHg
Density:1.615g/cm3
Index of Refraction:1.758
PSA:37.30000
Exact Mass:299.97900
LogP:4.45370
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Brom-phenanthren-10-carbonsaeure chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Brom-phenanthren-9-carbonsaeure physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-bromo-phenanthrene-9-carboxylic acid Use and application,6-Brom-phenanthren-9-carbonsaeure technical grade,usp/ep/jp grade.
Related News: With an up-to-date working knowledge of both established biocatalytic processes and the very latest techniques, a trusted API CDMO provider can offer a suite of technical capabilities, backed by highly trained personnel and a proven track record of consistent quality and regulatory compliance. octachloro-[1,4]dioxane manufacturers Mindset’s Family 1 compounds leverage state-of-the art modern drug design using conjugated and deuterated psilocybin and psilocin design strategies to improve on psilocybin’s potential toxicity and pharmacokinetic profiles. 4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Pentadecafluoro-3-octylamino-decanoic acid suppliers Plexxikon filed a lawsuit against the pharma giant in 2017, alledging that Tafinlar, a rival to its melanoma drug Zelboraf that was brought to market in collaboration with Roche, has stepped on its intellectual property. The jury ruled in its favor, adding that the infringement is in fact willful. 3H-1,2,4-Triazole-3-thione, 4-[2-(dimethylamino)ethyl]-2,4-dihydro- vendor & factory.
